利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

12 条记录 (耗时 0.021 秒)

    Phloroglucinol derivatives having selectin ligand activity
    5.
    发明授权
    Phloroglucinol derivatives having selectin ligand activity 有权

    公开(公告)号：US08278356B2

    公开(公告)日：2012-10-02

    申请号：US13032760

    申请日：2011-02-23

    申请人： Ewald Aydt ,  Remo Kranich

    发明人： Ewald Aydt ,  Remo Kranich

    IPC分类号： A61K31/185 ,  C07C33/26 ,  C07C33/28

    摘要： Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning —X— is e.g. and Y being e.g. or the pharmaceutically acceptable salts, esters or amides and prodrugs can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or selectin binding.

    Phloroglucinol derivatives having selectin ligand activity
    10.
    发明授权
    Phloroglucinol derivatives having selectin ligand activity 失效
    具有选择蛋白配体活性的间苯三酚衍生物

    公开(公告)号：US08461207B2

    公开(公告)日：2013-06-11

    申请号：US13032760

    申请日：2011-02-23

    申请人： Ewald Aydt ,  Remo Kranich

    发明人： Ewald Aydt ,  Remo Kranich

    IPC分类号： A61K31/185 ,  C07C33/26 ,  C07C33/28

    CPC分类号： C07C235/38 ,  C07D213/30 ,  C07D213/40 ,  C07D213/75

    摘要： Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning —X— is e.g. and Y being e.g. or the pharmaceutically acceptable salts, esters or amides and prodrugs can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or selectin binding.

    摘要翻译： 包含至少一种式（I）化合物和药学上可接受的载体的药物组合物，其可用于药物中，其中符号和取代基具有以下含义-X-为例如。 而Y是例如 或药学上可接受的盐，酯或酰胺和前药可用于调节由E-，P-或选择蛋白结合介导的体外和体内结合过程。